¼¼°èÀÇ ¾Ï Ä¡·á ½Ã¼³ ¾Ï Ä¡·á ½Ã¼³ ½ÃÀå
Cancer Treatment Facilities
»óǰÄÚµå : 1777908
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 382 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,204,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,612,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¾Ï Ä¡·á ½Ã¼³ ¼¼°è ½ÃÀåÀº 2030³â±îÁö 725¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 484¾ï ´Þ·¯·Î ÃßÁ¤µÇÁö¸¸ Ä¡·á ½Ã¼³ ¼¼°è ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGR 7.0%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 725¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÌÁö¸¸ ¼ö¼úÀº CAGR 7.7%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á±îÁö 410¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. È­Çпä¹ý ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£À» ÅëÇØ¼­ CAGR 6.8%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 132¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 11.0%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¾Ï Ä¡·á ½Ã¼³ ½ÃÀåÀº 2024³â¿¡ 132¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 152¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 11.0%·Î ÃßÁ¤µË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 3.4%¿Í 6.8%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.6%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ ¾Ï Ä¡·á ½Ã¼³ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

÷´Ü ¾Ï Ä¡·á ½Ã¼³¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀϱî?

¼¼°èÀûÀ¸·Î ¾Ï ¹ßº´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Á¾ÇÕÀûÀ̰í Àü¹®ÀûÀÎ Ä¡·á¸¦ Á¦°øÇÏ´Â ÃÖ÷´Ü ¾Ï Ä¡·á ½Ã¼³¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Àα¸ °í·ÉÈ­, »ýȰ½À°üÀÇ º¯È­, ȯ°æÀû ¿äÀÎÀ¸·Î ÀÎÇØ ¾Ï ¹ß»ý·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÀÇ·á ±â°üµéÀº ÃÖ÷´Ü Ä¡·á ±â¼úÀ» °®Ãá ÷´Ü Á¾¾çÇÐ ¼¾ÅÍ¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½Ã¼³Àº Á¶±â Áø´Ü, Á¤¹Ð Ä¡·á, ´ÙÇÐÁ¦Àû Ä¡·á¸¦ Á¦°øÇÏ¿© ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

°¡Ä¡ ±â¹Ý ÀÇ·á·ÎÀÇ Àüȯµµ ¾Ï Ä¡·á ½Ã¼³ÀÇ ¹ßÀüÀ» Çü¼ºÇϰí ÀÖ½À´Ï´Ù. Á¤ºÎ¿Í ¹Î°£ ÀÇ·á ¼­ºñ½º Á¦°ø¾÷üµéÀº ÷´Ü Áø´Ü µµ±¸, ·Îº¿ ¼ö¼ú, Ç¥Àû Ä¡·á, ÁöÁö ¿ä¹ý ¼­ºñ½º¸¦ ¾Ï ¼¾ÅÍ¿¡ ÅëÇÕÇÏ´Â µ¥ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾ç¼ºÀÚ Ä¡·á, AI¸¦ Ȱ¿ëÇÑ Áø´Ü, °³ÀÎ ¸ÂÃãÇü ÀÇ·áÀÇ ºÎ»óÀ¸·Î ±âÁ¸ Ä¡·á ¼¾ÅÍÀÇ ¾÷±×·¹ÀÌµå ¹× Á¾¾ç Àü¹® º´¿ø ½Å¼³¿¡ ´ëÇÑ ÅõÀÚ°¡ Àü ¼¼°èÀûÀ¸·Î Ȱ¹ßÈ÷ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº ¾Ï Ä¡·á ¼¾Å͸¦ ¾î¶»°Ô º¯È­½Ã۰í Àִ°¡?

¾Ï Ä¡·á ½Ã¼³ÀÇ ±â¼ú ÅëÇÕÀº ȯÀÚ Ä¡·á¿¡ Çõ¸íÀ» ÀÏÀ¸Å°°í Ä¡·á È¿°ú¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù. AI¿Í ¸Ó½Å·¯´×Àº ÇöÀç ¾ÏÀÇ Á¶±â ¹ß°ß¿¡ Ȱ¿ëµÇ°í ÀÖÀ¸¸ç, Á¾¾ç Àü¹®Àǰ¡ Á¾¾çÀ» °¡Àå Ãʱ⿡ Ä¡·áÇÒ ¼ö ÀÖ´Â ´Ü°è¿¡¼­ Á¾¾çÀ» ½Äº°ÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾ç¼ºÀÚ¼± Ä¡·á¿Í °°Àº Á¤¹Ð ¹æ»ç¼± Ä¡·á´Â ¾Ï¼¼Æ÷¿¡ °í¼±·®ÀÇ ¹æ»ç¼±À» Á¶»çÇϸ鼭 °Ç°­ÇÑ Á¶Á÷ÀÇ ¼Õ»óÀ» ÃÖ¼ÒÈ­Çϰí ÀÖ½À´Ï´Ù.

¶Ç ´Ù¸¥ Áß¿äÇÑ ¹ßÀüÀº ·Îº¿ º¸Á¶ ¼ö¼úÀÇ È°¿ëÀÔ´Ï´Ù. ·Îº¿ º¸Á¶ ¼ö¼úÀº º¸´Ù Á¤¹ÐÇÑ ÃÖ¼Òħ½À ¼ö¼úÀ» °¡´ÉÇÏ°Ô Çϰí, ȸº¹ ½Ã°£À» ´ÜÃàÇϸç, ¼ö¼ú ¼ºÀûÀ» Çâ»ó½Ãŵ´Ï´Ù. ¿ø°ÝÀÇ·á¿Í µðÁöÅÐ Çコ Ç÷§ÆûÀº ¶ÇÇÑ Àü¹® ¾Ï Àü¹®ÀÇ¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» È®´ëÇÏ¿©, ƯÈ÷ ÀÇ·áÇýÅÃÀ» ÃæºÐÈ÷ ¹ÞÁö ¸øÇÏ´Â Áö¿ªÀÇ È¯Àڵ鿡°Ô ¿ø°Ý Áø·á¿Í ¼¼ÄÁµå ¿ÀÇǴϾðÀ» °¡´ÉÇÏ°Ô Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿¬±¸ ÁÖµµÇü ¾Ï¼¾ÅÍ¿¡¼­´Â ȯÀÚÀÇ À¯ÀüÀû ±¸¼º¿¡ µû¶ó Ä¡·á °èȹÀ» ¸ÂÃãÈ­Çϱâ À§ÇØ À¯Àüü ½ÃÄö½ÌÀ» ÅëÇÕÇÏ¿© º¸´Ù È¿°úÀûÀÌ°í ¸ÂÃã Ä¡·á·Î À̾îÁö°í ÀÖ½À´Ï´Ù.

½ÃÀå µ¿ÇâÀº ¾Ï Ä¡·á ½Ã¼³ °³Ã´¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÄ¡°í Àִ°¡?

Á¾ÇÕÀûÀÎ ¾Ï Ä¡·á ¸ðµ¨·ÎÀÇ ÀüȯÀ¸·Î È­Çпä¹ý, ¹æ»ç¼±¿ä¹ý, ¸é¿ª¿ä¹ý, ÁöÁö¿ä¹ý µîÀÇ Ä¡·á¹ýÀ» º¹ÇÕÀûÀ¸·Î Á¦°øÇÏ´Â ÅëÇվϼ¾ÅͰ¡ ¼³¸³µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¾ÇÕÀûÀÎ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ ȯÀÚµéÀº ¿øÈ°Çϰí Çù·ÂÀûÀÎ Ä¡·á¸¦ ¹ÞÀ» ¼ö ÀÖÀ¸¸ç, »ýÁ¸À²°ú »îÀÇ ÁúÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¾Ï Ä¡·á ½Ã¼³ÀÇ È®´ë´Â Å« È帧À̸ç, Á¤ºÎ ¹× ¹Î°£ ÅõÀÚÀÚµéÀÌ ¾Æ½Ã¾Æ, Áßµ¿, ¾ÆÇÁ¸®Ä«¿¡ ÷´Ü Á¾¾çº´¿øÀ» °Ç¼³Çϰí ÀÖ½À´Ï´Ù. Àü¹®ÀûÀÎ ¾Ï Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó, ¹Î°ü ÆÄÆ®³Ê½ÊÀº ÀÇ·á °ÝÂ÷¸¦ ÇØ¼ÒÇÏ°í ¼¼°èÀû ¼öÁØÀÇ ¾Ï ÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» È®´ëÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, À£ºù, Æí¾ÈÇÔ, Á¤½Å °Ç°­ Áö¿ø¿¡ ÁßÁ¡À» µÐ ȯÀÚ Áß½ÉÀÇ ¼³°è ¿øÄ¢ÀÌ ÃֽŠ¾Ï¼¾ÅÍ¿¡ Àû¿ëµÇ¾î Àü¹ÝÀûÀÎ Ä¡·á °æÇèÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù.

½ÃÀåÀÇ ÁÖ¿ä ¼ºÀå ÃËÁø¿äÀÎÀº ¹«¾ùÀΰ¡?

¾Ï Ä¡·á ½Ã¼³ ½ÃÀåÀÇ ¼ºÀå ¿øµ¿·ÂÀº ¾Ï ¹ßº´·ü Áõ°¡, ±Þ¼ÓÇÑ ±â¼ú ¹ßÀü, Àü¹®ÀûÀÎ ¾Ï Ä¡·áÀÇ Çʿ伺ÀÔ´Ï´Ù. AI, ·Îº¿°øÇÐ, Á¤¹ÐÀÇ·á¿¡ ´ëÇÑ ÅõÀÚ·Î Ä¡·á ¼º°ú¸¦ ³ôÀ̰í ÃֽŠ¾Ï¼¾ÅÍÀÇ ¿ª·®À» È®ÀåÇϰí ÀÖ½À´Ï´Ù. °¡Ä¡¿¡ ±â¹ÝÇÑ ÇコÄɾîÀÇ ÃßÁø°ú ÀüÀÎÀû Ä¡·á Á¢±Ù¹ýÀÇ ÅëÇÕµµ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ, Á¾¾çÇÐ ÀÎÇÁ¶ó¿¡ ´ëÇÑ Á¤ºÎ Àڱݰú ¹Î°£ ÅõÀڴ ƯÈ÷ ½ÅÈï °æÁ¦±¹¿¡¼­ »õ·Î¿î ¾Ï Ä¡·á ¼¾ÅÍÀÇ °³¹ßÀ» °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. ¿ø°Ý ÀÇ·á¿Í µðÁöÅÐ Á¾¾çÇÐ ¼­ºñ½ºÀÇ µîÀåÀº ȯÀÚÀÇ Àü¹®°¡ Ä¡·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» ´õ¿í º¯È­½Ã۰í ÀÖÀ¸¸ç, ¿ø°ÝÁö¿¡ °ÅÁÖÇÏ´Â »ç¶÷µéµµ ÷´Ü ¾Ï Ä¡·áÀÇ ÇýÅÃÀ» ´©¸± ¼ö ÀÖµµ·Ï Çϰí ÀÖ½À´Ï´Ù. ¾Ï ¿¬±¸¿Í Ä¡·á¹ýÀÌ °è¼Ó ¹ßÀüÇϰí ÀÖ´Â °¡¿îµ¥, Á¶»ç±â¹ý ½ÃÀåÀº ¾ÕÀ¸·Îµµ Áö¼ÓÀûÀÎ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.

ºÎ¹®

Ä¡·á À¯Çü(¾Ï ¼ö¼ú, È­Çпä¹ý, ¹æ»ç¼± ¿ä¹ý, È£¸£¸ó ¿ä¹ý, ±âŸ Ä¡·á À¯Çü), ¾Ï À¯Çü(Ç÷¾×¾Ï, À¯¹æ¾Ï, Àü¸³¼±¾Ï, ¼ÒÈ­±â ¾Ï, ºÎÀΰú ¾Ï, È£Èí±â/Æó¾Ï, ±âŸ ¾Ï À¯Çü), Á¦°ø¾÷ü(º´¿ø, ¾Ï Ä¡·á ¼¾ÅÍ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ¼­, ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Cancer Treatment Facilities Market to Reach US$72.5 Billion by 2030

The global market for Cancer Treatment Facilities estimated at US$48.4 Billion in the year 2024, is expected to reach US$72.5 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2024-2030. Cancer Surgery, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$41.0 Billion by the end of the analysis period. Growth in the Chemotherapy segment is estimated at 6.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$13.2 Billion While China is Forecast to Grow at 11.0% CAGR

The Cancer Treatment Facilities market in the U.S. is estimated at US$13.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$15.2 Billion by the year 2030 trailing a CAGR of 11.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Cancer Treatment Facilities Market - Key Trends & Drivers Summarized

Why Is the Demand for Advanced Cancer Treatment Facilities Growing?

The increasing global burden of cancer has led to a heightened demand for state-of-the-art cancer treatment facilities that offer comprehensive and specialized care. With cancer rates rising due to aging populations, lifestyle changes, and environmental factors, healthcare institutions are investing heavily in advanced oncology centers equipped with cutting-edge treatment technologies. These facilities are crucial in delivering early diagnosis, precision treatments, and multidisciplinary care to improve patient outcomes.

The transition toward value-based healthcare is also shaping the development of cancer treatment facilities. Governments and private healthcare providers are focusing on integrating advanced diagnostic tools, robotic surgeries, targeted therapies, and supportive care services into cancer centers. Additionally, the rise of proton therapy, AI-driven diagnostics, and personalized medicine has fueled investments in upgrading existing treatment centers and building new specialized oncology hospitals worldwide.

How Are Technological Advancements Transforming Cancer Treatment Centers?

The integration of technology in cancer treatment facilities is revolutionizing patient care and enhancing treatment efficacy. AI and machine learning are now being used for early cancer detection, enabling oncologists to identify tumors at their earliest and most treatable stages. Moreover, precision radiation therapy, such as proton beam therapy, is minimizing damage to healthy tissues while delivering high-dose radiation to cancer cells.

Another key advancement is the use of robotic-assisted surgeries, which allow for minimally invasive procedures with higher precision, reducing recovery time and improving surgical outcomes. Telemedicine and digital health platforms are also expanding access to expert oncologists, enabling remote consultations and second opinions, particularly for patients in underserved regions. Additionally, research-driven cancer centers are integrating genomic sequencing to customize treatment plans based on a patient’s genetic makeup, leading to more effective and personalized therapies.

How Are Market Trends Impacting Cancer Treatment Facility Development?

The shift toward comprehensive cancer care models has led to the establishment of integrated cancer centers that offer a combination of treatment modalities, including chemotherapy, radiation, immunotherapy, and supportive care. This holistic approach ensures that patients receive seamless and coordinated care, improving survival rates and quality of life.

Additionally, the expansion of cancer treatment facilities in emerging markets is a major trend, with governments and private investors building advanced oncology hospitals in Asia, the Middle East, and Africa. As demand for specialized cancer care grows, public-private partnerships are playing a key role in bridging healthcare gaps and expanding access to world-class oncology services. Moreover, patient-centric design principles are being incorporated into modern cancer centers, with a focus on wellness, comfort, and mental health support to improve the overall treatment experience.

What Are the Key Growth Drivers in the Market?

The growth in the cancer treatment facilities market is driven by increasing cancer prevalence, rapid technological advancements, and the need for specialized oncology care. Investments in AI, robotics, and precision medicine are enhancing treatment outcomes and expanding the capabilities of modern cancer centers. The push for value-based healthcare and the integration of holistic treatment approaches are also contributing to the market’s expansion.

Furthermore, government funding and private investments in oncology infrastructure are accelerating the development of new cancer treatment centers, particularly in emerging economies. The rise of telemedicine and digital oncology services is further transforming patient access to expert care, ensuring that even remote populations can benefit from advanced cancer treatments. As cancer research and treatment methodologies continue to evolve, the cancer treatment facilities market is expected to experience sustained growth in the coming years.

SCOPE OF STUDY:

The report analyzes the Cancer Treatment Facilities market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment Type (Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy, Other Treatment Types); Cancer Type (Blood Cancer, Breast Cancer, Prostate Cancer, Gastrointestinal Cancer, Gynecologic Cancer, Respiratory/Lung Cancer, Other Cancer Types); Provider (Hospitals, Cancer Treatment Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â